Largest biotech by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Kodiak Sciences has the lowest figure of the 24 biotech ranked by total assets, at TRY 17.7B, followed by Scholar Rock Holding (TRY 20.4B) and ImmunityBio (TRY 25.3B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Kodiak SciencesTRY 17.7B
- Median
- TRY 128.9B
- Combined market value
- TRY 42.32T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Kodiak SciencesKOD · Health Care | TRY 17.7B | TRY 317B | TRY 4,846.96 | 0.72% down | 396% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | TRY 20.4B | TRY 291.2B | TRY 2,387.16 | 4.99% up | 14% up | ||
| 3 | ImmunityBioIBRX · Health Care | TRY 25.3B | TRY 354.7B | TRY 333.39 | 5.59% up | 193% up | ||
| 4 | Adaptive BiotechnologiesADPT · Health Care | TRY 25.9B | TRY 229.5B | TRY 1,417.77 | 1.33% down | 88% up | ||
| 5 | Twist BioscienceTWST · Health Care | TRY 32.4B | TRY 395.5B | TRY 5,800.21 | 2.68% up | 340% up | ||
| 6 | CG OncologyCGON · Health Care | TRY 39.9B | TRY 358.4B | TRY 4,012.23 | 0.77% up | 85% up | ||
| 7 | ImmunovantIMVT · Health Care | TRY 48.3B | TRY 351B | TRY 1,696.18 | 1.26% up | 43% up | ||
| 8 | Krystal BiotechKRYS · Health Care | TRY 67.3B | TRY 461.2B | TRY 15,562.97 | 3.35% up | 46% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | TRY 87.9B | TRY 518.8B | TRY 6,076.60 | 0.86% down | 87% up | ||
| 10 | CRISPR TherapeuticsCRSP · Health Care | TRY 114.3B | TRY 202B | TRY 2,082.02 | 2.81% up | 21% down | ||
| 11 | Revolution MedicinesRVMD · Health Care | TRY 118.8B | TRY 1.74T | TRY 8,064.06 | 1.72% down | 131% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | TRY 127.4B | TRY 556.9B | TRY 4,884.53 | 0.91% up | 37% up | ||
| 13 | Bio-TechneTECH · Health Care | TRY 130.5B | TRY 576.2B | TRY 3,668.00 | 0.13% up | 26% up | ||
| 14 | ExelixisEXEL · Health Care | TRY 143.5B | TRY 847.7B | TRY 3,474.07 | 0.55% up | 63% up | ||
| 15 | RepligenRGEN · Health Care | TRY 148.8B | TRY 549.5B | TRY 8,596.92 | 5.10% up | 5% up | ||
| 16 | VaxcytePCVX · Health Care | TRY 151.4B | TRY 470.3B | TRY 2,970.97 | 0.83% down | 22% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | TRY 233.6B | TRY 828.8B | TRY 8,188.38 | 2.15% down | 20% up | ||
| 18 | QiagenQGEN · Health Care | TRY 316.8B | TRY 516.3B | TRY 2,500.14 | 0.36% down | 12% up | ||
| 19 | argenxARGX · Health Care | TRY 437.9B | TRY 3T | TRY 47,711.26 | 0.16% down | 4% up | ||
| 20 | ModernaMRNA · Health Care | TRY 622.3B | TRY 4.1T | TRY 10,128.62 | 2.89% down | 755% up | ||
| 21 | BioNTechBNTX · Health Care | TRY 1.23T | TRY 1.05T | TRY 4,237.68 | 0.99% down | 16% down | ||
| 22 | BiogenBIIB · Health Care | TRY 1.48T | TRY 1.86T | TRY 12,577.12 | 0.57% down | 49% up | ||
| 23 | Gilead SciencesGILD · Health Care | TRY 2.98T | TRY 10.54T | TRY 8,501.59 | 1.00% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | TRY 4.57T | TRY 12.2T | TRY 22,547.18 | 2.38% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4366 TRY).
Questions and answers
Which biotech have the lowest total assets?
Kodiak Sciences (TRY 17.7B), Scholar Rock Holding (TRY 20.4B) and ImmunityBio (TRY 25.3B) have the lowest total assets of the 24 biotech ranked here as of 18 Nov 2026, 16:15 UTC.
How many biotech are in this ranking?
24 are ranked by total assets.
What are these biotech worth together?
The 24 biotech ranked by total assets have a combined market value of TRY 42.32T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.